GSK plc Transaction Notification

This filing reports on several transactions by GSK plc involving ordinary shares and American Depositary Shares (ADS). Key individuals, including Lynn Baxter (President, Europe), Julie Brown (Chief Financial Officer), James Ford (SVP and Group General Counsel), David Redfern (President, Corporate Development), Regis Simard (President, Global Supply Chain), Philip Thomson (President, Global Affairs), Deborah Waterhouse (CEO, ViiV Healthcare and President, Global Health), and Maya Martinez-Davis (President, US), made acquisitions of ordinary shares under the Company's Share Reward Plan. These acquisitions occurred on March 10, 2026, at a price of £20.7168 per share on the London Stock Exchange. Additionally, Maya Martinez-Davis acquired notional ADS on March 9, 2026, for $55.5100 per ADS on the New York Stock Exchange as part of her GSK Executive Supplemental Savings Plan account. All transactions were initial notifications.